Minimally invasive left atrial appendage (LAA) clip insertion after challenging LAA occluder implantation to minimize the risk of stroke.
Ayse CetinkayaMohamed ZeriouhOliver-Joannis LiakopoulosStefan HeinTamo SiemonsPeter BramlageMarkus SchönburgYeong-Hoon ChoiManfred RichterPublished in: Journal of surgical case reports (2020)
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, requiring lifelong anticoagulation or interventional, transseptal left atrial appendage (LAA) occluder implantation to minimize stroke risk. Incomplete LAA closure post implantation is a frequent observation. Incomplete LAA occlusion after transseptal occluder implantation necessitates anticoagulation in cases of persistent AF to minimze risk of embolism and/or apoplexy. Patients with contraindications to lifelong anticoagulation therapy are challenging to treat and alternative options are needed. We present a case of a patient with persistent AF who underwent frustraneous LAA occluder implantation. The patient's anatomy necessitated surgical closure of the LAA, which was accomplished with an LAA clip 4 weeks after implantation. The patient was discharged in excellent clinical status 5 days after the surgery. No further complications were observed within the following year.
Keyphrases
- atrial fibrillation
- left atrial appendage
- catheter ablation
- oral anticoagulants
- left atrial
- minimally invasive
- direct oral anticoagulants
- heart failure
- case report
- percutaneous coronary intervention
- stem cells
- venous thromboembolism
- left ventricular
- risk factors
- brain injury
- bone marrow
- coronary artery disease
- coronary artery bypass
- mesenchymal stem cells
- robot assisted